The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with ...

Breast Cancer Awareness Month brings attention to important advancements in cancer care, and today, we're partnering with ...

The market for multiplex biomarker imaging is anticipated to reach a valuation of USD 1,631.4 million by 2034, up from USD ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

Researchers at the University of California San Diego are hoping to drastically shorten the time between a cancer diagnosis ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

By getting CGP test results in the hands of pathologists and oncologists at the onset of a cancer diagnosis, we witnessed CGP-tested patients received biomarker-matched therapy at a higher rate, which ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

The research team looked at cell-free DNA fragmentation profiles across the genome combined with measurements of two key biomarkers to detect ovarian cancer.

Xiaoguang Dong, assistant professor of mechanical engineering at Vanderbilt University, is leading a team of researchers that ...

Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure timely and effective biomarker testing for patients with early-stage NSCLC.